Skip to main content
. Author manuscript; available in PMC: 2026 Jun 24.
Published in final edited form as: Lancet Child Adolesc Health. 2025 Feb;9(2):100–111. doi: 10.1016/S2352-4642(24)00330-4

Table 5.

Clinical predictors of treatment success versus death and treatment failure among children and adolescents treated for rifampicin-resistant tuberculosis stratified by age

Clinical predictor Treatment success versus unfavourable outcomes (death/treatment failure)
Age < 5 years Age 5 to <10 years Age 10 to <15 years Age 15–19 years
Univariable logistic regression models Multivariable logistic regression model Univariable logistic regression models Multivariable logistic regression model Univariable logistic regression models Multivariable logistic regression model Univariable logistic regression models Multivariable logistic regression model
Crude OR (95% CI) p-value aOR (95% CI) p-value Crude OR (95% CI) p-value aOR (95% CI) p-value Crude OR (95% CI) p-value aOR (95% CI) p-value Crude OR (95% CI) p-value aOR (95% CI) p-value
Upper-middle or high-income country 5.24 (0.1.5–18.3) 0.0095 - - 2.37 (0.85–6.59) 0.097 - - 1.5 (0.83–2.72) 0.17 - - 0.82 (0.55–1.22) 0.33 - -
Age (years) 1.16 (0.96–1.4) 0.13 1.17 (0.97–1.42) 0.11 0.94 (0.82–1.07) 0.37 1.01 (0.87–1.16) 0.94 0.90 (0.84–0.96) 0.0025 0.91 (0.85–0.98) 0.011 0.99 (0.95–1) 0.37 0.99 (0.96–1) 0.82
Male sex 0.87 (0.56–1.37) 0.55 0.84 (0.53–1.35) 0.47 1.07 (0.74–1.56) 0.72 1.08 (0.73–1.59) 0.71 0.75 (0.61–0.91) 0.0045 0.75 (0.61–0.92) 0.0067 0.86 (0.79–0.93) 0.00038 0.87 (0.79–0.95) 0.0015
HIV positive 0.29 (0.16–0.52) <0.0001 0.3 (0.16–0.56) 0.00016 0.34 (0.19–0.59) 0.00013 0.49 (0.27–0.89) 0.019 0.39 (0.29–0.53) <0.0001 0.42 (0.30–0.58) <0.0001 0.4 (0.34–0.47) <0.0001 0.39 (0.33–0.46) <0.0001
Microbiologically confirmed tuberculosis 0.68 (0.29–1.6) 0.37 - - 0.37 (0.17–0.81) 0.012 - - 1.32 (0.98–1.78) 0.070 - - 1.6 (1.4–1.83) <0.0001 - -
Previous tuberculosis treatment 0.76 (0.39–1.5) 0.42 0.96 (0.47–1.94) 0.47 0.51 (0.33–0.80) 0.0036 0.64 (0.39–1.05) 0.080 0.45 (0.36–0.57) <0.0001 0.51 (0.40–0.66) 0.011 0.48 (0.43–0.55) <0.0001 0.51 (0.45–0.58) <0.0001
Pulmonary tuberculosis 0.5 (0.14–1.82) 0.30 0.6 (0.16–2.26) 0.44 0.27 (0.08–0.96) 0.043 0.30 (0.08–1.11) 0.071 0.45 (0.16–1.24) 0.45 0.52 (0.18–1.47) 0.21 0.59 (0.36–0.96) 0.032 0.53 (0.32–0.89) 0.017
Extrapulmonary tuberculosis 1.61 (0.51–2.64) 0.72 - - 1.51 (0.75–3.04) 0.25 - - 1.84 (1.26–2.68) 0.0019 - - 1.5 (1.12–2) 0.0081 - -
AFB smear positive 0.33 (0.18–0.59) 0.00022 0.34 (0.19–0.63) 0.00054 0.31 (0.20–0.48) <0.0001 0.35 (0.21–0.60) <0.0001 0.47 (0.37–0.59) <0.0001 0.48 (0.38–0.6) <0.0001 0.47 (0.4–0.56) <0.0001 0.46 (0.39–0.54) <0.0001

AFB, acid-fast bacilli; OR, odds ratio; aOR, adjusted OR